FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:LRIG3-SLC16A7

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: LRIG3-SLC16A7
FusionPDB ID: 49699
FusionGDB2.0 ID: 49699
HgeneTgene
Gene symbol

LRIG3

SLC16A7

Gene ID

121227

9194

Gene nameleucine rich repeats and immunoglobulin like domains 3solute carrier family 16 member 7
SynonymsLIG3MCT2
Cytomap

12q14.1

12q14.1

Type of geneprotein-codingprotein-coding
Descriptionleucine-rich repeats and immunoglobulin-like domains protein 3LIG-3monocarboxylate transporter 2solute carrier family 16 (monocarboxylate transporter), member 7solute carrier family 16, member 7 (monocarboxylic acid transporter 2)
Modification date2020031320200313
UniProtAcc

Q6UXM1

Main function of 5'-partner protein: FUNCTION: May play a role in craniofacial and inner ear morphogenesis during embryonic development. May act within the otic vesicle epithelium to control formation of the lateral semicircular canal in the inner ear, possibly by restricting the expression of NTN1 (By similarity). {ECO:0000250}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000320743, ENST00000379141, 
ENST00000543448, ENST00000261187, 
ENST00000549465, ENST00000549588, 
ENST00000552024, ENST00000547379, 
ENST00000552432, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score10 X 8 X 8=6409 X 8 X 7=504
# samples 1212
** MAII scorelog2(12/640*10)=-2.41503749927884
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(12/504*10)=-2.0703893278914
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: LRIG3 [Title/Abstract] AND SLC16A7 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: LRIG3 [Title/Abstract] AND SLC16A7 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)LRIG3(59267837)-SLC16A7(60165000), # samples:2
Anticipated loss of major functional domain due to fusion event.LRIG3-SLC16A7 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
LRIG3-SLC16A7 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneSLC16A7

GO:1901475

pyruvate transmembrane transport

9786900



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:59267837/chr12:60165000)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across LRIG3 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across SLC16A7 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000379141LRIG3chr1259267837-ENST00000552432SLC16A7chr1260165000+47532999442181404
ENST00000379141LRIG3chr1259267837-ENST00000547379SLC16A7chr1260165000+45292999442181404
ENST00000320743LRIG3chr1259267837-ENST00000552432SLC16A7chr1260165000+5156340222146211466
ENST00000320743LRIG3chr1259267837-ENST00000547379SLC16A7chr1260165000+4932340222146211466
ENST00000379141LRIG3chr1259267836-ENST00000552432SLC16A7chr1260164999+47532999442181404
ENST00000379141LRIG3chr1259267836-ENST00000547379SLC16A7chr1260164999+45292999442181404
ENST00000320743LRIG3chr1259267836-ENST00000552432SLC16A7chr1260164999+5156340222146211466
ENST00000320743LRIG3chr1259267836-ENST00000547379SLC16A7chr1260164999+4932340222146211466

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000379141ENST00000552432LRIG3chr1259267837-SLC16A7chr1260165000+0.0001401180.9998598
ENST00000379141ENST00000547379LRIG3chr1259267837-SLC16A7chr1260165000+0.0001859690.9998141
ENST00000320743ENST00000552432LRIG3chr1259267837-SLC16A7chr1260165000+0.0002174890.9997825
ENST00000320743ENST00000547379LRIG3chr1259267837-SLC16A7chr1260165000+0.0002970310.999703
ENST00000379141ENST00000552432LRIG3chr1259267836-SLC16A7chr1260164999+0.0001401180.9998598
ENST00000379141ENST00000547379LRIG3chr1259267836-SLC16A7chr1260164999+0.0001859690.9998141
ENST00000320743ENST00000552432LRIG3chr1259267836-SLC16A7chr1260164999+0.0002174890.9997825
ENST00000320743ENST00000547379LRIG3chr1259267836-SLC16A7chr1260164999+0.0002970310.999703

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for LRIG3-SLC16A7

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
LRIG3chr1259267836SLC16A7chr12601649992999998PEPASVASSNSFMGPVSSVLVNKYGS
LRIG3chr1259267836SLC16A7chr126016499934021060PEPASVASSNSFMGPVSSVLVNKYGS
LRIG3chr1259267837SLC16A7chr12601650002999998PEPASVASSNSFMGPVSSVLVNKYGS
LRIG3chr1259267837SLC16A7chr126016500034021060PEPASVASSNSFMGPVSSVLVNKYGS

Top

Potential FusionNeoAntigen Information of LRIG3-SLC16A7 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
LRIG3-SLC16A7_59267836_60164999.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:13FMGPVSSV0.99580.89431119
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:38FMGPVSSV0.99220.81041119
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:22FMGPVSSVL0.99550.91911120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:67FMGPVSSVL0.99310.8771120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:30FMGPVSSVL0.99310.8771120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:24FMGPVSSVL0.99310.8771120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:11FMGPVSSVL0.99280.8891120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:60FMGPVSSVL0.99280.87271120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:21FMGPVSSVL0.99080.92511120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:27FMGPVSSVL0.98860.86331120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:13FMGPVSSVL0.98780.90961120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:04FMGPVSSVL0.98740.87251120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:17FMGPVSSVL0.98550.8161120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-B46:01FMGPVSSVL0.98430.78071120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:16FMGPVSSVL0.98160.84661120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:35FMGPVSSVL0.97930.89091120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:29FMGPVSSVL0.97710.87431120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:20FMGPVSSVL0.96410.88161120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:19FMGPVSSVL0.95860.82141120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:38FMGPVSSVL0.95410.87671120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-B48:01FMGPVSSVL0.76090.85051120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:17SFMGPVSSV0.70530.86741019
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-B07:10SFMGPVSSV0.03870.65341019
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:19FMGPVSSVLV0.99540.79931121
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C01:17MGPVSSVL0.99970.98321220
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C01:30MGPVSSVL0.99960.98261220
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C03:19FMGPVSSVL0.99910.99671120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C12:16FMGPVSSVL0.99870.99311120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C03:07FMGPVSSVL0.99790.99431120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C03:08FMGPVSSVL0.99720.98041120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C05:09FMGPVSSVL0.99690.97721120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C04:06FMGPVSSVL0.99650.98951120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:02FMGPVSSVL0.99570.89251120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C04:10FMGPVSSVL0.99530.97131120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:05FMGPVSSVL0.99470.92571120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-B15:04FMGPVSSVL0.99470.99231120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C04:07FMGPVSSVL0.99460.96691120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:07FMGPVSSVL0.99330.89121120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C08:13FMGPVSSVL0.99320.99291120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C08:04FMGPVSSVL0.99320.99291120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:01FMGPVSSVL0.99310.8771120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C04:14FMGPVSSVL0.99160.96421120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C08:15FMGPVSSVL0.99060.99241120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C01:17FMGPVSSVL0.98860.98661120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C08:03FMGPVSSVL0.9720.99661120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C03:14FMGPVSSVL0.97130.99481120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-B15:21FMGPVSSVL0.96880.98551120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C02:06FMGPVSSVL0.95460.99211120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C07:13FMGPVSSVL0.9510.99021120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C01:30FMGPVSSVL0.93430.98681120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C07:29FMGPVSSVL0.91020.98991120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C01:17MGPVSSVLV0.64080.97771221
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C01:30MGPVSSVLV0.62440.97411221
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C04:14SFMGPVSSV0.59990.97521019
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C12:16SFMGPVSSV0.35140.99371019
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C07:13SFMGPVSSV0.30680.99051019
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C07:10SFMGPVSSV0.3020.99191019
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C07:29SFMGPVSSV0.29950.98831019
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C04:07SFMGPVSSV0.08550.97471019
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C01:02MGPVSSVL0.99970.98271220
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C01:03MGPVSSVL0.99970.97121220
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:03FMGPVSSV0.99620.92651119
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C12:02FMGPVSSVL0.99970.99391120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C03:03FMGPVSSVL0.99920.99671120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C03:04FMGPVSSVL0.99920.99671120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C03:05FMGPVSSVL0.99830.98311120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C03:67FMGPVSSVL0.99830.99511120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C03:17FMGPVSSVL0.99820.99111120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C03:06FMGPVSSVL0.99710.99721120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C05:01FMGPVSSVL0.99690.97721120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C03:02FMGPVSSVL0.99670.99171120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C04:03FMGPVSSVL0.99650.96321120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:03FMGPVSSVL0.99580.93031120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-B15:73FMGPVSSVL0.99550.99581120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C18:01FMGPVSSVL0.99480.95731120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C04:01FMGPVSSVL0.99460.96691120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C04:04FMGPVSSVL0.99450.98711120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:14FMGPVSSVL0.99110.91221120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A02:06FMGPVSSVL0.99080.92511120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C08:02FMGPVSSVL0.99060.99241120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C01:02FMGPVSSVL0.990.9861120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-B15:30FMGPVSSVL0.98920.99261120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C01:03FMGPVSSVL0.98920.97941120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C08:01FMGPVSSVL0.9720.99661120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C07:04FMGPVSSVL0.97180.96931120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-B35:13FMGPVSSVL0.94830.98581120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C02:02FMGPVSSVL0.93920.99421120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C02:10FMGPVSSVL0.93920.99421120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-B07:13FMGPVSSVL0.92060.9111120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-B08:12FMGPVSSVL0.9110.98411120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C17:01FMGPVSSVL0.79470.98611120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-B15:09FMGPVSSVL0.78970.96181120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C01:03MGPVSSVLV0.74270.96591221
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C01:02MGPVSSVLV0.68210.97681221
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C04:04SFMGPVSSV0.58470.95241019
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C06:02SFMGPVSSV0.55780.99871019
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C06:17SFMGPVSSV0.55780.99871019
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-B40:21FMGPVSSVL0.34550.71551120
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C03:67SFMGPVSSV0.28810.99551019
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C06:08SFMGPVSSV0.27270.99731019
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C07:04SFMGPVSSV0.18250.98551019
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C06:06SFMGPVSSV0.15780.99691019
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C18:01SFMGPVSSV0.09760.97381019
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C04:01SFMGPVSSV0.08550.97471019
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C14:03SFMGPVSSV0.06960.99161019
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C14:02SFMGPVSSV0.06960.99161019
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A68:02NSFMGPVSSV0.99310.8437919
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-A69:01NSFMGPVSSV0.98960.9526919
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C14:02SFMGPVSSVL0.96240.98821020
LRIG3-SLC16A7chr1259267836chr12601649993402HLA-C14:03SFMGPVSSVL0.96240.98821020

Top

Potential FusionNeoAntigen Information of LRIG3-SLC16A7 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)

Top

Fusion breakpoint peptide structures of LRIG3-SLC16A7

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
634ASSNSFMGPVSSVLLRIG3SLC16A7chr1259267836chr12601649993402

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of LRIG3-SLC16A7

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN634ASSNSFMGPVSSVL-7.9962-8.1096
HLA-B14:023BVN634ASSNSFMGPVSSVL-5.70842-6.74372
HLA-B52:013W39634ASSNSFMGPVSSVL-6.83737-6.95077
HLA-B52:013W39634ASSNSFMGPVSSVL-4.4836-5.5189
HLA-A11:014UQ2634ASSNSFMGPVSSVL-10.0067-10.1201
HLA-A11:014UQ2634ASSNSFMGPVSSVL-9.03915-10.0745
HLA-A24:025HGA634ASSNSFMGPVSSVL-6.56204-6.67544
HLA-A24:025HGA634ASSNSFMGPVSSVL-5.42271-6.45801
HLA-B44:053DX8634ASSNSFMGPVSSVL-7.85648-8.89178
HLA-B44:053DX8634ASSNSFMGPVSSVL-5.3978-5.5112
HLA-A02:016TDR634ASSNSFMGPVSSVL-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of LRIG3-SLC16A7

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
LRIG3-SLC16A7chr1259267836chr12601649991019SFMGPVSSVCTTTCATGGGTCCTGTAAGTAGTGTTT
LRIG3-SLC16A7chr1259267836chr12601649991020SFMGPVSSVLCTTTCATGGGTCCTGTAAGTAGTGTTTTGG
LRIG3-SLC16A7chr1259267836chr12601649991119FMGPVSSVTCATGGGTCCTGTAAGTAGTGTTT
LRIG3-SLC16A7chr1259267836chr12601649991120FMGPVSSVLTCATGGGTCCTGTAAGTAGTGTTTTGG
LRIG3-SLC16A7chr1259267836chr12601649991121FMGPVSSVLVTCATGGGTCCTGTAAGTAGTGTTTTGGTGA
LRIG3-SLC16A7chr1259267836chr12601649991220MGPVSSVLTGGGTCCTGTAAGTAGTGTTTTGG
LRIG3-SLC16A7chr1259267836chr12601649991221MGPVSSVLVTGGGTCCTGTAAGTAGTGTTTTGGTGA
LRIG3-SLC16A7chr1259267836chr1260164999919NSFMGPVSSVATTCTTTCATGGGTCCTGTAAGTAGTGTTT

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence

Top

Information of the samples that have these potential fusion neoantigens of LRIG3-SLC16A7

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
SARCLRIG3-SLC16A7chr1259267836ENST00000320743chr1260164999ENST00000547379TCGA-DX-A1KU

Top

Potential target of CAR-T therapy development for LRIG3-SLC16A7

check button Predicted 3D structure. We used RoseTTAFold.
262_LRIG3-SLC16A7_t000_.e2e.pdb


check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneLRIG3chr12:59267836chr12:60164999ENST00000320743-1819810_83010381120.0TransmembraneHelical
HgeneLRIG3chr12:59267836chr12:60164999ENST00000379141-1819810_8309781060.0TransmembraneHelical
HgeneLRIG3chr12:59267837chr12:60165000ENST00000320743-1819810_83010381120.0TransmembraneHelical
HgeneLRIG3chr12:59267837chr12:60165000ENST00000379141-1819810_8309781060.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000026118715116_1360479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000026118715149_1690479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000026118715174_1940479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000026118715247_2670479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000026118715283_3030479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000026118715313_3330479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000026118715339_3590479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000026118715374_3940479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000026118715407_4270479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST000002611871590_1100479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000054737926116_1360479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000054737926149_1690479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000054737926174_1940479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000054737926247_2670479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000054737926283_3030479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000054737926313_3330479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000054737926339_3590479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000054737926374_3940479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000054737926407_4270479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST000005473792690_1100479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000055202437116_1360479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000055202437149_1690479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000055202437174_1940479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000055202437247_2670479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000055202437283_3030479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000055202437313_3330479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000055202437339_3590479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000055202437374_3940479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000055202437407_4270479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST000005520243790_1100479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000055243226116_1360479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000055243226149_1690479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000055243226174_1940479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000055243226247_2670479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000055243226283_3030479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000055243226313_3330479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000055243226339_3590479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000055243226374_3940479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST0000055243226407_4270479.0TransmembraneHelical
TgeneSLC16A7chr12:59267836chr12:60164999ENST000005524322690_1100479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000026118715116_1360479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000026118715149_1690479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000026118715174_1940479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000026118715247_2670479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000026118715283_3030479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000026118715313_3330479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000026118715339_3590479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000026118715374_3940479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000026118715407_4270479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST000002611871590_1100479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000054737926116_1360479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000054737926149_1690479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000054737926174_1940479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000054737926247_2670479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000054737926283_3030479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000054737926313_3330479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000054737926339_3590479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000054737926374_3940479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000054737926407_4270479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST000005473792690_1100479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000055202437116_1360479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000055202437149_1690479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000055202437174_1940479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000055202437247_2670479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000055202437283_3030479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000055202437313_3330479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000055202437339_3590479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000055202437374_3940479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000055202437407_4270479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST000005520243790_1100479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000055243226116_1360479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000055243226149_1690479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000055243226174_1940479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000055243226247_2670479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000055243226283_3030479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000055243226313_3330479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000055243226339_3590479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000055243226374_3940479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST0000055243226407_4270479.0TransmembraneHelical
TgeneSLC16A7chr12:59267837chr12:60165000ENST000005524322690_1100479.0TransmembraneHelical

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result
LRIG3chr1259267836ENST00000320743SLC16A7chr1260164999ENST00000547379
LRIG3chr1259267836ENST00000379141SLC16A7chr1260164999ENST00000547379

Top

Related Drugs to LRIG3-SLC16A7

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to LRIG3-SLC16A7

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource